openPR Logo
Press release

Tagraxofusp - API Insight, 2018

04-22-2019 08:48 AM CET | Health & Medicine

Press release from: Tagraxofusp - Pharma Proff

Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3.

Download the sample report @ https://www.pharmaproff.com/request-sample/1168

Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after being designed with the title of breakthrough therapy, priority review, and orphan drug status.

Get the detailed analysis @ https://www.pharmaproff.com/report/tagraxofusp

Tagraxofusp is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients over 2 years old.

This treatment allows an alternative for the previous intense treatment which consisted of intensive chemotherapy followed by bone marrow transplantation. Some of the side-effects include fatigue, peripheral edema and weight increase.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1168

This report provides details of the drug and the API manufacturers across the 7 major markets which includes U.S, EU5, and Japan. It includes the overview, mechanism, regulatory milestones, strategic developments, the historical and forecasted sales.
The pipeline analysis of the drug by phase which would include the product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tagraxofusp - API Insight, 2018 here

News-ID: 1711863 • Views: 373

More Releases for Elzonris

Pediatric Clinical Trials Market Key Findings with Worldwide Top Companies Syneo …
Pediatric clinical trials play a major role in modern healthcare, as pediatric clinical trials are the only criteria to launch new drugs in market for various indications that affect pediatric population and therefore pharmaceutical and biotechnological industries have been gradually shifting from in-house clinical research to contract research organization (CRO). The global pediatric clinical trials market size was valued at US$ 9,885.7 million in 2017, and is expected to exhibit a
Pediatric Clinical Trials Market Key Findings with Worldwide Top Companies Syneo …
Global Pediatric Clinical Trials Market, by Clinical Trial Phase (Pre-clinical, Phase I, Phase II, and Phase III), by Study Design (Interventional, [Randomized Trial, Non-randomized Trial, Crossover Trial], and Observational), by Medical Condition (Neuropsychiatric Conditions, Infectious Diseases, Maternal and Perinatal Conditions, Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases, Diabetes, Nutritional Deficiencies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$
Pediatric Clinical Trials Market In Depth Analysis, Size and Top Players Pharmac …
Pediatric clinical trials play a major role in modern healthcare, as pediatric clinical trials are the only criteria to launch new drugs in market for various indications that affect pediatric population and therefore pharmaceutical and biotechnological industries have been gradually shifting from in-house clinical research to contract research organization (CRO). The global pediatric clinical trials market size was valued at US$ 9,885.7 million in 2017, and is expected to exhibit a
Pediatric Clinical Trials Market financials, Competitive landscaping and Key Pla …
Pediatric clinical trials play a major role in modern healthcare, as pediatric clinical trials are the only criteria to launch new drugs in market for various indications that affect pediatric population and therefore pharmaceutical and biotechnological industries have been gradually shifting from in-house clinical research to contract research organization (CRO). The global pediatric clinical trials market size was valued at US$ 9,885.7 million in 2017, and is expected to exhibit a